在巴布亚新几内亚南飞区的结核病计划结果通过COVID-19得到维持
M Bauri1, S Vaccher2, T Marukutira2
1Western Provincial Health Authority, Daru, Papua New Guinea.
Public health action
|December 2, 2024
概括
这项关于巴布亚新几内亚耐药结核病 (DR-TB) 的研究发现,尽管有COVID-19的影响,但病例报告率很高. 加强先前存在的卫生系统可能确保了弹性,并维持了治疗的成功.
科学领域:
- 公共卫生 公共卫生
- 传染病流行病学 传染病流行病学
- 全球健康 全球健康
背景情况:
- 巴布亚新几内亚 (PNG) 面临着巨大的结核病 (TB) 负担,特别是耐药性结核病 (DR-TB),在偏远地区,如南飞区 (SFD).
- 在全球范围内,COVID-19大流行给已建立的结核病控制计划带来了挑战,引发了人们对诊断和治疗中潜在的干扰的担忧.
研究的目的:
- 评估2017年至2022年TB和DR-TB病例通知和治疗结果的趋势,并将其纳入SFD.
- 评估COVID-19流行病对结核病方案干预和患者人口统计学在这种高负担环境中的影响.
主要方法:
- 一项回顾性队列研究分析了从达鲁岛,SFD,PNG例行收集的结核病计划数据.
- 在COVID前 (2017-2019) 和COVID (2020-2022) 期间,结核病例报告和治疗结果的比较.
主要成果:
- 总共有3,751例结核病病例被注册,其中19.6%患有DR-TB. 病例报告率异常高 (达鲁地区为1792/100,000).
- 尽管2019-2021年病例通知减少了29.2%,但在COVID期间,细菌学确认增加了. 儿童和DR-TB的通知减少了.
- 在大流行期间,对药物敏感 (86.5%) 和抗药性结核病 (83.6%) 的治疗成功率仍然很高.
结论:
- 疫情前卫生系统的加强和PNG的社区参与可能促进了对COVID-19中断的抵御力.
- 持续高结核病病例通知表明正在进行传播,需要加强公共卫生干预.
- 尽管存在挑战,但结核病计划表现出适应性,在资源有限的环境中保持高的治疗成功率.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis IV
133
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
133
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Pulmonary Tuberculosis III
303
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
303
Pneumonia IV: Management
299
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
299


